AHB Lab is the Taiwan biotech pioneer company focusing on the devel- opment and supply of novel biosynthetic peptide and their commercialized products with self-developed core technology “Synthetic Biology Peptido- mimetic Platform (SBPP)”. SBPP is completed in mass production process for dipeptides to henicosapeptide with low-cost and high-yield way, aiming at peptide-based therapy relevant in cosmetics, nutraceuticals, medicine. At present, 11 biosynthetic peptide materials and 4 biosynthetic peptide-based series of products have been completed.
